Similarly, down-regulation of SnoN, a negative regulator of TGF-β signaling, has been shown to enhance both EMT in lung and breast cancer cells [48] and TGF-β-induced expression of ADAM12 [49]. This evidence concerns the gene TGFB1 and breast cancer.